Searched for
NANOMI TECHNOLOGY
Lupin launches generic injection in US with 180-day exclusivityIn an exciting development for mental health treatment, Lupin has introduced a generic version of a medication for schizophrenia and bipola...- Lupin seeks strategic partnerships for long-acting injectable platformDrug firm Lupin has launched a strategic partnership program to expand the reach of its subsidiary Nanomi BV's long-acting injectable platf...
- Lupin gets USFDA nod for generic risperidone extended-release injectable suspensionLupin Ltd. secured USFDA approval for its generic risperidone extended-release injectable suspension, a treatment for schizophrenia and bip...
- Lupin to set up two new R&D centres in USLupin had also increased research and development spending to Rs 958.28 crore in FY'14 as compared to Rs 770.85 crore in the FY'13.
- Lupin acquires Netherlands-based Nanomi BV, focus on injectiblesNanomi has a rich talent pool of scientists who would be backed by Lupin's global R&D and manufacturing teams, the Mumbai-based firm said.
- Lupin rallies 4.5% in a weak market post Q3 results; top Nifty gainerLupin rallied as much as 4.8% in trade on Monday in a weak market, after the drugmaker reported a 42% growth in its quarterly net profit.
Load More